Amélie Boulais
Head of Market Entry Strategy, Virus Based Therapeutics at Sartorius.
The Rise of mRNA: New Era, New Challenges
September 21, 2021
mRNA vaccines have provided one good answer to humankind’s latest grand challenge, but the technology has yet to mature. If the success story of these nucleotide-based drugs is to continue, manufacturers must look to ease the headaches associated with their manufacture.
1 min read
Biopharma Trends to Watch
March 19, 2021
Five trends that will shape the future of biopharma manufacturing in 2021
1 min read
Success at Speed Part 4: Commercial Manufacturing
October 12, 2020
Part 4 – how to prepare for the rapid set-up of commercial manufacturing
0 min read
Success at Speed Part 5: Reducing Costs
October 16, 2020
Part 5 – reducing costs. Global access to the vaccine is essential to provide protection against the virus. A big hurdle to accessibility will likely be price. The key is to strike a balance between price and development costs.
0 min read
Success at Speed Part 6: Logistics and Global Availability
October 20, 2020
Part 6 – logistics and global availability. A vaccine must be able to reach patients who need it. Reliable partners and procedures are a must.
0 min read
Success at Speed: Digging into Accelerated Vaccine Development (Part 1)
August 6, 2020
Part 1 – the need for speed and safety. As the world grasps the severity of the ongoing pandemic, we must ask how we can accelerate vaccine development safely – for COVID-19 and other therapeutic areas.
0 min read
Success at Speed Part 2: Regulatory Considerations
August 6, 2020
Part 2 – regulatory considerations. It is well accepted that vaccine development needs to move faster, but what are the regulatory considerations and how can companies balance compliance and speed?
0 min read
Success at Speed Part 7: Progress So Far
December 1, 2020
Part 7 – Progress so far. There is a promising pipeline of vaccine candidates, but what happens if the frontrunners fail?
1 min read
Success at Speed Part 8: Lessons to be Learned
December 4, 2020
Part 8 – Lessons to be learned. What have we learned from the pandemic and how can we address the coming challenges?
1 min read
The Pandemic Diaries
November 10, 2020
We ask medicine makers around the world to tell us how their professional and personal lives have changed over the course of the COVID-19 crisis
1 min read
Newsletters
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
